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This study estimated the prevalence and distribution of human papillomavirus (HPV) types among women with
cervical intraepithelial neoplasia (CIN) grade III and invasive cervical cancer from Goiás (Brazil Central Region).
Seventy-four cases were analyzed and consisted of 18 CIN III, 48 squamous cell carcinomas, 4 adenocarcinomas, 1
adenosquamous carcinoma and 3 undifferentiated carcinomas. HPV-DNA sequences were examined in formalin-
fixed and paraffin-embedded tissues using primers from L1 region GP5+/GP6+. Polymerase chain reaction  prod-
ucts were typed with dot blot hybridization using probes for HPV 16, 18, 31, 33, 45, 54, 6/11, 42/43/44, 51/52, 56/
58. The prevalence of HPV was estimated to be 76% (56/74). HPV 16 was the most frequently found type, followed
by HPV 33, 18 and 31. The prevalence of untyped HPV was 6%; 79% percent of the squamous cell carcinoma cases
and 61% percent of the CIN III were positive for HPV and the prevalence rate of HPV types was the same for the total
number of cases. According to other studies, HPV type 16 is the most prevalent virus in all Brazilian regions, but
there is variation regarding to other types. Type 18 is the second most prevalent HPV in North, Southeast and South
Brazil regions and types 31 and 33 are the second most prevalent HPV in Northeast and Central Brazil, respectively.
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Many epidemiological studies indicate that human
cancer is a multifactorial disease, which can develop
through different molecular biologic pathways. Currently
there is compelling evidence that the development of hu-
man cervical cancer without the involvement of the spe-
cific human papillomavirus (HPV) is exceptional or impos-
sible (Walboomers & Meijer 1997).
The International Biological Study on Cervical Cancer
demonstrated that 92.9% of cervical cancer from 22 coun-
tries contained HPV-DNA, ranging from 75 to 100% (Bosch
et al. 1995). Variations in HPV-DNA prevalence are highly
dependent on the technique used. A higher prevalence is
assayed by polymerase chain reaction (PCR) than by other
methods (de Roda Husman et al. 1995, Syrjanen &
Syrjanen 2000). Walboomers et al. (1999) showed that HPV
is present in 99.7% of patients with invasive cervical can-
cer, when PCR based and serologic assays were used.
Evidence suggests that the HPV E6 oncoprotein can bind
to p53 protein and promote its degradation which is con-
sistent with the low frequency of p53 mutation reported
in these tumor as compared with other cancers (Pinheiro
& Villa 2001).
Studies of Brazilian women showed that HPV DNA
prevalence in invasive cervical cancer ranged from 55.2%
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when using non-isotopic in-situ hybridization to 91% when
using PCR-based assays (Cavalcanti et al. 1994, 2000, Eluf-
Neto et al. 1994, Bosch et al. 1995, Gonçalves et al. 1999,
Noronha et al. 1999, Lorenzato et al. 2000).
The prevalence of HPV types found in cervical cancer
shows worldwide geographical variations (Bosch et al.
1995). In Brazil, a country with almost continental propor-
tions, studies of HPV prevalence in cervical cancer from
four of its five regions are available. All these published
studies showed that HPV 16 is the predominant type in
cities of the Northern, Northeast, Southeast and South-
ern regions, although there are regional variations with
regard to other types (Cavalcanti et al. 1994, Eluf-Neto et
al. 1994, Bosch et al. 1995, Gonçalves et al. 1999, Noronha
et al. 1999, Lorenzato et al. 2000).
In the Central Region of Brazil, cervical cancer is the
second most common malignancy, with the exclusion of
skin cancer, and is the second most common cause of
death among women (Brasil 2001). However, no informa-
tion regarding HPV-DNA prevalence and distribution is
available. Thus, the aim of our study was to determine the
prevalence of different HPV types among women with
cervical intraepithelial neoplasia (CIN III) and invasive
cancer from Goiânia, a city situated in Central Brazil.
MATERIALS AND METHODS
Eighty-six cases of  CIN III and invasive cervical can-
cer were initially included in this study. All samples were
obtained from patients who had undergone hysterectomy
at Araújo Jorge Hospital in the city of Goiânia (State of
Goiás) between November 1997 and November 1998. Tu-
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mor tissues were fixed in buffered formalin during 14 to 18
h and embedded in paraffin. Serial sections from each block
were made: the first sections were stained with
haematoxylin-eosin to be histopathologically examined,
while the remaining ones were used for DNA preparation
and analysis. The section blade was replaced after each
specimen block to avoid contamination between samples.
All HPV testing was done at the Ludwig Institute for
Cancer Research, São Paulo Branch. Twelve cases were
excluded: 6 due to lack of enough representative neoplas-
tic areas in the block after histopathological evaluation
and 6 because they were β-globin-negative. The 74
analysed cases consisted of 18 CIN III, 48 squamous cell
carcinomas, 4 adenocarcinomas, 1 adenosquamous carci-
noma and 3 undifferentiated carcinomas.
DNA was extracted according to the protocol devel-
oped by Pinto and Villa (1998). Samples were initially di-
gested with proteinase K (200 µg/ml), followed by DNA
purification using the Glass Max DNA Isolation Spin Car-
tridge System (GIBCO/BRL Gaithesburg, Maryland, USA),
an ion exchange column. After purification, the samples
were submitted to PCR with β-globin primers G73 (5'-
GAAGAGCCAAGGACAGGTAC-3') and G74 (5'-
CAACTTCATCCACGTTCACC-3') resulting in a 268 base
pair amplicon to exclude false-negative results, serving
as an internal control to evaluate the integrity and suffi-
ciency of the DNA present in the sample (Greer et al. 1991).
For detection of HPV-DNA, general primers GP5+ (5'
TTTGTTACTGTGGTAGATACTAC-3') and GP6+ (5'
GAAAAATAAACTGTAAAT CATATTC 3') were used
to amplify a fragment of about 150 bp (de Roda Husman et
al. 1995, Pinto & Villa 1998). PCR products were typed
with dot-blot hybridization using probes 16, 18, 31, 33, 45,
54, 6/11, 42/43/44, 51/52, 56/58 labeled with P32 (γATP).
RESULTS
The mean age of the patients was 49.1 years, ranging
from 27 to 83 years. The majority of women (76%) were
aged between 31 and 60 years.
The total prevalence of HPV for all cases included was
76%. HPV 16 was the most frequently recognized type,
followed by HPV types 33, 18 and 31. The prevalence of
untyped HPV with probes used in this study was 6%.
Taking only squamous cell carcinoma cases into account,
HPV prevalence was 79%, and the prevalence rate of HPV
types was the same for the total number of cases. Sixty-
one percent of the patients with CIN III were positive for
HPV-DNA and HPV 16 was the most prevalent. Four cases
of adenocarcinomas were positive for HPV-DNA, three of
these were type 16 and one was type 18. Three cases of
undifferentiated carcinomas were positive for HPV-DNA,
two of these were positive for type 16. The single case of
adenosquamous carcinoma was negative for HPV-DNA
(Table I).
Taking only HPV-DNA positive cases into consider-
ation, HPV 16 was detected in 71% of squamous cell car-
cinomas and in 73% of the total number of cases. These
rates were over five times higher than HPV type 33, which
was the second most frequent type found (Table II).
TABLE I
 Prevalence of papillomavirus types according to histopathologic diagnoses
Cervical
Human intraepithelial Squamousc- Adenocarcinoma Adenosquamous Undifferentiated
papillomavirus neoplasia III carcinoma carcinoma carcinoma carcinoma Total
n (%) n (%) n (%) n (%) n (%) n (%)
16   9   50 27   56 3   75 -  - 2   67 41   56
33   1    6 5   10 - - -  - -  - 6    8
Untyped -  - 3    6 - - -  - 1   33 4    6
18 -  - 2    4 1   25 -  - -  - 3    4
31   1    6 1    2 - - -  - -  - 2    3
HPV positive 11   61 38   79 4  100 -  - 3  100 56   76
HPV negative    7   39 10   21 - 1  100 -  - 18   24
Total 18  100 48  100 4  100 1  100 3  100 74  100
TABLE II
Frequency of specific types in positive papillomavirus cases
HPV Squamous Total
n (%) n (%)
16 27 (71) 41  (73)
33 5 (13) 6 (11)
Untypedd 3 (8) 4  (7)
18 2 (5) 3  (5)
31 1 (3) 2 (4)
Total 38 (100) 56 (100)
DISCUSSION
The International Biological Study on Cervical Cancer
showed HPV 16 as the most prevalent HPV type in all
countries with the exception of Indonesia, where HPV 18
was the most prevalent type. There were significant geo-
graphical variations in the prevalence of less common
types of HPV. A clustering of HPV type 45 was apparent
in Western Africa, while HPV 39 and 59 were almost en-
tirely confined to Central and South America. The five
most prevalent HPV types in Central and South America
are 16, 18, 45, 31 and 33 (Bosch et al. 1995).
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Table III summarizes HPV prevalence in invasive cer-
vical cancer from cities of each Brazilian region, including
results of the present study. The most prevalent HPV is
type 16 (Cavalcanti et al. 1994, Eluf-Neto et al. 1994, Bosch
et al. 1995, Noronha et al. 1999, Lorenzato et al. 2000). HPV
18 is the second most prevalent HPV type in the North,
Belém city (Noronha et al. 1999), Southeast, São Paulo
city (Eluf-Neto et al. 1994) and South, Porto Alegre city
(Bosch et al. 1995) and it is the third type in the Northeast,
Recife city (Lorenzato et al. 2000) and Central Brazil, Goiâ-
nia city. The second most prevalent HPV in the Northeast
(Lorenzato et al. 2000) is type 31 and in the Central region
it is type 33. Although HPV 45 is the third most prevalent
type in Central and South America, it was detected only
in the Southern region of Brazil (Bosch et al. 1995).
Data collected from the five continents showed that
HPV 33 is the fourth or fifth most prevalent type (Bosch et
al. 1995), while it was the second most prevalent type in
Goiânia.
The distribution of specific HPV types was similar in
squamous cell carcinomas and in the total number of can-
cer cases, since the former was the most frequent histo-
pathologic cancer detected. All cases of adenocarcino-
mas included in this study were HPV-DNA positive. De-
spite the small number of cases, HPV 18 was detected in
one case and HPV 16 in 3 cases. Adenocarcinomas are
less prevalent than squamous cell carcinomas, thus limit-
ing comparison of prevalence rates between these histo-
logic types (Zehbe & Wilander 1997).
In this study, the viral type failed to be identified in
four cases by the same probes utilized to identify most
high-risk types. Untyped HPV was a relatively common
finding in a large longitudinal investigation of the natural
history of HPV infection and cervical neoplasia in a low
income female patient population from São Paulo (Franco
et al. 1999). It is particularly interesting to observe whether
the distribution of HPV types reflects virus prevalence in
women whose cytologic examination is normal (Bosch et
al. 1995). The actual oncogenic potential of many types of
HPV, including new and rare ones, is still unknown, due to
the limited number of cases associated with neoplasms
(Meyer et al. 1998). The identification of HPV types in
cervical carcinomas indicates that oncogenic HPV may
be present among these rare HPV types (Bosch et al. 1995,
Meyer et al. 1998).
The total prevalence of HPV was 76%. These results
were similar to studies conducted by Baay et al. (1996),
Unger et al. (1998) and Noronha et al. (1999) who detected
HPV in 87.6%, 65%, and 70.3% of patients with invasive
cervical cancer, respectively. These authors used stored
formalin-fixed and paraffin-embedded tumor tissues for
PCR analysis. Although variables such as type of fixa-
tive, fixation time and type of primer had been controlled,
and despite the fact that the blocks were recently pre-
pared, it is possible that HPV-DNA prevalence was not
completely measured.
Studies have reported difficulties in reproducing PCR
results with formalin-fixed and paraffin-embedded tumor
tissues (Ben-Ezra et al. 1991, Bianchi et al. 1991, Thomp-
son & Rose 1991, Goodrow et al. 1992). It was observed
that studies using fresh tissue samples commonly report
HPV prevalences well over 90% (Bosch et al. 1995, Karisen
et al. 1995, Walboomers et al. 1999). Therefore, it is pos-
sible that if fresh frozen tumor tissues had been examined,
HPV prevalence might have been higher, since amplifica-
tion could be hampered by formalin fixation (Baay et al.
1996). Levi et al. (1998) detected higher prevalence of HPV
in fresh samples than paraffin-embedded tissues in cases
of penile carcinomas.
Moreover, recent studies have suggested a few pos-
sibilities to explain the occurrence of false-negative re-
sults mainly in high-grade squamous intraepithelial le-
sions and invasive cervical cancers. The linear integra-
tion of the circular HPV genome in the host cell’s chromo-
some can affect the PCR target region. Although the pref-
erential site of disruption is the E2 region, in some cases
the primer sequences may coincide with the disrupted
regions in the L1 region and this may affect HPV detec-
tion. According to Walboomers et al. (1999), the occur-
rence of false-negative results is due to the integration
events affecting L1 sequences that occur with different
HPV types.
TABLE III
 Prevalence of papillomavirus types in invasive cervical cancer in cities of each Brazilian region
Central a South b Southeast c North d Northeast e
n  56 n  46 n  186 n  147 n  59
Type % Type % Type % Type % Type %
16   57.1 16 52.2 16 53.8 16 43.5 16 59.3
33     8.9 18     8.7 18   8.6 18   8.2 31 11.9
18     5.4 31     4.3 31/33   3.2 Pool 13.6 18   5.1
31     1.8 45     4.3 Untyped 18.8 Untyped   6.8 33   5.1
Untyped     7.1 Others   17.4 Others   8.5
Any HPV 79 Any HPV 87 Any HPV 84.4 Any HPV 70.3 Any HPV
positive positive positive positive positive 89.8
HPV 21 HPV 13 HPV 15.6 HPV 29.7 HPV 10.2
negative negative negative negative negative
a: current study; b:Bosch et al. 1995; c:Eluf-Neto et al. 1994; d: Noronha et al. 1999; e: Lorenzato et al. 2000
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Other possible factors to consider, although rare, are
genotypes that show less amplification efficiency, which
are not detectable by the currently used primers (Kleter et
al. 1998).
Although the prevalence detected was lower in com-
parison to data from Walboomers et al. (1999), this study
provided knowledge about the prevalence of specific HPV
types in CIN III and invasive cervical cancer patients from
Goiás (Central Brazil). This information is relevant because
specific HPV types may pose different relative risks for
cancer. Moreover, the identification of HPV types which
are most commonly associated with cervical cancer in dif-
ferent regions has implications for cancer prevention strat-
egies, including the development of effective vaccines.
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